Best Practices in the CDMO Selection Process

We are pleased to bring you a new series on “Best Practices in the CDMO Selection Process”

Pharmaceutical development companies of all sizes frequently outsource their Active Pharmaceutical Ingredient (API) manufacturing to CDMOs for various reasons, including: a) limited internal know-how and capacity to manufacture API according to Good Manufacturing Practice (GMP) or b) to reduce costs and timelines.

The CDMO series provides sound advice to agile biotech companies in identifying and selecting the right Contract Development and Manufacturing Organization (CDMO) for advancing the development of their product(s), in conjunction with successfully managing a chosen CDMO to meet the company’s expectations.

In these articles, we will explore the common reasons why a company might consider engaging a CDMO. We will focus on how to the evaluate CDMOs, detail the best practices for working with a CDMO to ensure the success of your product development, and more.